 |
 Treatment Algorithms Articles
Textbook
Clinical Trials
Laboratory Research
Publications
Immunology Fellowship
List of Specialists
Low Vision
Instructions |
|
|
Home | News
| Links | How to Help
| Contact Us | Search
Medical Professionals: Publications: Articles:
Articles Published by the Ocular Immunology and Uveitis
Foundation
C. Stephen Foster, M.D.
In Print (551-600)
Previous 50 Next
50 All
|
551. |
Management of anterior uveitis: Immunomodulatory Therapy is gaining
acceptance. |
|
 |
Fortuna ES, Hinkle D, Foster CS.
Ophthalmology Management 2006;October; 61-101. No abstract available. |
|
|
552. |
Conjunctival non-caseating granulomas in a human immunodeficiency
virus (HIV) positive patient attributed to sarcoidosis. |
|
 |
Papadaki TG, Kafkala C, Zacharopoulos IP, Seyedahmadi B J, Dryja T, Foster
CS
Ocul Immunol Inflamm. 2006;14(5):309-11. |
|
|
553. |
Mooren ulcer: An immunopathologic study. |
|
|
|
Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas
B, Foster CS.
Cornea. 2006 Jul;25(6):667-73.
|
|
|
554. |
Chronic cicatrizing conjunctivitis in a patient with epidermolysis
bullosa acquisita. |
|
|
|
Letko E, Bhol K, Anzaar F, Perez VL, Ahmed AR, Foster CS.
Arch Ophthalmol.
2006 Nov;124(11):1615-1618. |
|
|
555. |
Plasmapheresis for lupus retinal vasculitis. |
|
|
|
Papadaki TG, Zacharopoulos IP, Papaliodis G, Iaccheri B, Fiore T, Foster CS.
Arch Ophthalmol. 2006 Nov;124(11):1654-6. |
|
|
556. |
PImmunomodulatory therapy for Vogt-Koyanagi-Harada patients as
first-line therapy. |
|
|
|
Paredes I, Ahmed M, Foster CS.
Ocul
Immunol Inflamm. 2006 Apr;14(2):87-90. |
|
|
557 |
Safety and efficacy of intravitreal triamcinolone acetonide for
uveitic macular edema.. |
|
|
|
Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS.
Ocul
Immunol Inflamm. 2005 Apr-Jun;13(2-3):205-12. |
|
|
558. |
Octreotide as a treatment for uveitic cystoid macular edema. |
|
|
|
Kafkala C, Choi JY, Choopong P, Foster CS.
Arch
Ophthalmol. 2006 Sep;124(9):1353-5. No abstract available. |
|
|
559. |
CSolitary myofibroma of the sclera. |
|
|
|
Choopong P, Nielsen PG, Perlman EM, Huang JJ, Dryja TP, Foster CS.
Cornea. 2007
Jan;26(1):114-6. |
|
|
560. |
Presumed oculoglandular syndrome from Bartonella quintana. |
|
|
|
Borboli S, Afshari NA, Watkins L, Foster CS.
Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):41-3. |
|
|
561. |
Sclerokeratitis and facial skin lesions: A case report of pyoderma
gangrenosum and its response to dapsone therapy. |
|
|
|
Teasley LA, Foster CS, Baltatzis S
Cornea. 2007
Feb;26(2):215-219. |
|
|
562. |
Intravitreal bevacizumab fortreatment of uveitic macular edema. |
|
|
|
Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS.
Ophthalmology.
2007 Mar 14. |
|
|
563. |
Punctate inner choroidopathy: A survey analysis of 77 persons. |
|
|
|
Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS,
Jabs DA, Nguyen QD.
Ophthalmology. 2007 Apr 13. |
|
|
564. |
Systemic immunomodulatory therapy in severe dry eye secondary to
inflammation. |
|
|
 |
Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):99-104. |
|
|
565. |
Biologic response modifier therapy for refractory childhood uveitis. |
|
|
|
Gallagher MJ, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster
CS.
Br J Ophthalmol. 2007 Jun 7; |
|
|
566 |
Syphilis: An ophthalmologic update. |
|
|
 |
Teasley LA, Foster CS.
Int Ophthalmol Clin. 2007 Spring;47(2):133-44. Review. No
abstract available |
|
|
567. |
Adamantiades-Bechet disease: diagnosis and current concepts in
management of ocular manifestations. |
|
|
|
Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS,
Jabs DA, Nguyen QD.
Compr Ophthalmol Update. 2007 Jul-Aug;8(4):225-33. Review |
|
|
568. |
Intravitreal clindamycin for toxoplasmic retinochoroiditis. |
|
|
|
Sobrin L, Kump LI, Foster CS.
Retina.
2007 Sep;27(7):952-7. |
|
|
569. |
Relative risk for cancer in mucous membrane pemphigoid associated
with antibodies to the beta4 integrin subunit. |
|
|
|
Letko E, Gürcan HM, Papaliodis GN, Christen W, Foster CS, Ahmed AR.
Clin Exp Dermatol. 2007 Nov;32(6):637-41. Epub 2007 May 25. |
|
|
570. |
The characteristic features of optical coherence tomography in
posterior uveitis. |
|
|
|
Gallagher MJ, Yilmaz T, Cervantes-Castañeda RA, Foster CS.
Br J Ophthalmol. 2007 Dec;91(12):1680-5. Epub 2007 Jun 25.
Review. |
|
|
571. |
Coma MC, Yilmaz T, Foster CS. |
|
|
|
Tumour necrosis factor-alpha in
conjunctivae affected by ocular cicatricial pemphigoid.
Acta
Ophthalmol Scand. 2007 Nov;85(7):753-5. Epub 2007 May 4.
|
|
|
572. |
The Boston Keratoprosthesis in
Stevens-Johnson Syndrome. |
|
|
|
Sayegh RR, Ang LP, Foster CS, Dohlman CH.
Am J
Ophthalmol. 2008 Jan 18. |
|
|
573 |
Methods for identifying long-term
adverse effects of treatment in patients with eye diseases: the
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort
Study. |
|
|
|
Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO,
Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA,
Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB.
Ophthalmic
Epidemiol. 2008 Jan-Feb;15(1):47-55. |
|
|
574 |
Daclizumab for treatment of birdshot
chorioretinopathy. |
|
|
 |
Sobrin L, Huang JJ, Christen W, Kafkala C, Choopong P, Foster CS.
Arch
Ophthalmol. 2008 Feb;126(2):186-91. |
|
|
575 |
Diagnosis of limited
ophthalmic Wegener granulomatosis: distinctive pathologic features
with ANCA test confirmation. |
|
|
|
Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N,
Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW,
Caya JG, Foster CS.
Int
Ophthalmol. 2008 Feb;28(1):35-46. Epub 2007 Jun 23. |
|
|
576 |
Tubulointerstitial nephritis
and uveitis syndrome. |
|
|
|
Hinkle DM, Foster CS..
Int Ophthalmol Clin. 2008 Spring;48(2):9-13. |
|
|
577 |
Cataract surgery in children
with juvenile idiopathic arthritis associated uveitis. |
|
|
|
Acevedo S, Quinones K, Rao V, Cervantes-Castañeda RA, Foster CS.
Int Ophthalmol Clin. 2008 Spring;48(2):1-7. No abstract
available. |
|
|
578. |
Long-term Risk of Malignancy
Among Patients Treated With Immunosuppressive Agents for Ocular
Inflammation: A Critical Assessment of the Evidence. |
|
|
|
Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB,
Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer
KJ.
Am J Ophthalmol. 2008 Jun 23; |
|
|
579. |
Biologic response modifier
therapy for psoriatic ocular inflammatory disease. |
|
|
|
Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS.
2008 May-Ocul Immunol InflammJun;16(3):89-93. |
|
|
580. |
Primary intraocular lymphoma: Another
great masquerader. |
|
|
|
Gallagher MJ, Cervantes-Castaneda RC, Bhat P, Yilmaz T, Foster CS.
Eur J Ophthalmol. 2008 Jul-Aug;18(4):567-71. |
|
|
581. |
Subconjunctival bevacizumab for corneal neovascularization. |
|
|
|
Doctor PP, Bhat PV, Foster CS.
Cornea. 2008
Oct;27(9):992-5. |
|
|
582. |
Induction of durable remission in ocular inflammatory diseases. |
|
|
|
Cervantes-Castaneda RA, Bhat P, Fortuna E, Acevedo S, Foster CS.
Eur
J Ophthalmol. 2009 Jan-Feb;19(1):118-23. |
|
|
583. |
Intravenous daclizumab for recalcitrant ocular inflammatory disease |
|
|
|
Bhat P, Castañeda-Cervantes RA, Doctor PP, Foster
CS.
Graefes Arch Clin Exp Ophthalmol. 2009 Feb 6. |
|
|
584. |
Outcomes of cataract surgery in children with chronic uveitis. |
|
|
|
Quiñones K, Cervantes-Castañeda RA, Hynes AY, Daoud
YJ, Foster CS.
J Cataract
Refract Surg. 2009 Apr;35(4):725-31. |
|
|
585. |
Conjunctival/corneal intraepithelial neoplasia. |
|
|
|
Hamam R, Bhat P, Foster CS.
Int Ophthalmol
Clin. 2009 Winter;49(1):63-70. Review. No abstract available.
|
|
|
586. |
Serum soluble interleukin-2 receptor levels do not correlate with an
associated systemic disease in patients with uveitis. |
|
|
|
Papadaki T, Iaccheri B, Fiore T, Zacharopoulos I,
Thadani S, Christen W, Androudi S, Foster CS.
Acta Ophthalmol. 2009 Jun 2. |
|
|
587. |
Acute Posterior Multifocal Placoid Pigment Epitheliopathy: Outcome
and Visual Prognosis. |
|
|
|
Fiore T, Iaccheri B, Androudi S, Papadaki TG,
Anzaar F, Brazitikos P, D'Amico DJ, Foster CS.
Retina. 2009 May 27. |
|
|
588. |
Vogt-Koyanagi-Harada syndrome associated with bilateral serous
macular detachments responsive to immunomodulatory therapy. |
|
|
|
Gallagher MJ, Yilmaz T, Foster CS.
Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):345-7.
|
|
|
589. |
Pterygia: pathogenesis and the role of subconjunctival bevacizumab
in treatment. |
|
|
|
Mauro J, Foster CS.
Semin Ophthalmol. 2009 May-Jun;24(3):130-4. |
|
|
590. |
Intravitreal bevacizumab for uveitic choroidal neovascularization. |
|
|
|
Doctor PP, Bhat P, Sayed R, Foster CS.
Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):118-26. |
|
|
591. |
Intravenous daclizumab for recalcitrant ocular inflammatory disease. |
|
|
|
Bhat P, Castañeda-Cervantes RA, Doctor PP, Foster
CS.
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):687-92.
Epub 2009 Feb 6. |
|
| 594. |
Overall and
cancer related mortality among patients with ocular inflammation
treated with immunosuppressive drugs: retrospective cohort study. |
|
|
Kempen JH, Daniel E,
Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA,
Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB,
Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE.
BMJ. 2009 Jul
3;339:b2480. doi: 10.1136/bmj.b2480. |
Previous 50 Next
50 All
|
